title: Successful treatment of MDS with lenalidomide, complicated by transient autoimmune hemolysis.
authors: Wan-Ling
authors: WL
authors: Sun
authors: Leonhard
authors: L
authors: Köck
authors: Alois
authors: A
authors: Walder
authors: Martin
authors: M
authors: Erdel
authors: Susanne
authors: S
authors: Kilga-Nogler
authors: Harald
authors: H
authors: Schennach
authors: Michael
authors: M
authors: Fiegl
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced* / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000009:adverse effects; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use; D000077269:Lenalidomide; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000188:drug therapy*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007136:Immunoglobulins; D013792:Thalidomide; D000077269:Lenalidomide; D008775:Methylprednisolone